A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigat

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate to severe chronic peripheral neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Open

Protocol code: M602011079
EudraCT code: No aplica
Research group: Clinical Pharmacology
Service: Anesthesia
Principal investigator: Medel Rebollo, Francisco Javier
Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Phase: Fase II